3 research outputs found
Eozinofilni kolitis
Zbog nedefiniranih kriterija dijagnostike i velikog broja sekundarnih uzroka eozinofilije kolona, ova je bolest Äesto kasno prepoznata. Bolesnici se prezentiraju s nespecifiÄnim simptomima, kao Å”to su abdominalna bol, proljev i gubitak na težini, a kliniÄka slika ponajviÅ”e ovisi o dubini infiltracije stijenke eozinofilima. Eozinofilni kolitis ima bimodalnu dobnu distribuciju s najÄeÅ”Äom pojavnosti u novoroÄenÄadi i mlaÄoj odrasloj populaciji. ToÄan uzrok ove bolesti nije poznat. Dok je u novoroÄenÄadi to najÄeÅ”Äe IgE posredovan odgovor na kravlje mlijeko i proteine soje, u odraslih je najÄeÅ”Äe rezultat CD4 Th2 odgovora. Endoskopskim pregledom zamijeÄene promjene stijenke kolona nespecifiÄne su, uslijed Äega je potrebna biopsija za potvrdu dijagnoze i iskljuÄenje drugih moguÄih bolesti. Upalne bolesti crijeva, lijekovi, paraziti, autoimune bolesti vezivnoga tkiva, te idiopatski hipereozinofilni sindrom, mogu stvoriti sliÄnu kliniÄku i histoloÅ”ku sliku bolesti, zbog Äega je eozinofilni kolitis primarno dijagnoza iskljuÄenja. U djece je bolest nakon uvedene dijete samolimitirajuÄa, dok je u odraslih potrebno dugotrajno lijeÄenje s obzirom na to da je bolest kroniÄna tijeka s razdobljima remisije i relapsa. NajuÄinkovitijom se pokazala kortikosteroidna terapija, a u sluÄaju teÅ”kih refraktornih stanja i razvoja steroidne ovisnosti, uvodi se imunosupresivna terapija
Eosinophilic colitis
Zbog nedefiniranih kriterija dijagnostike i velikog broja sekundarnih uzroka eozinofilije kolona ova je bolest Äesto kasno prepoznata. Pacijenti se prezentiraju s nespecifiÄnim simptomima kao Å”to su abdominalna bol, proljev i gubitak na težini, a kliniÄka slika ponajviÅ”e ovisi o dubini infiltracije stijenke eozinofilima. Eozinofilni kolitis ima bimodalnu dobnu distibuciju s najÄeÅ”Äom pojavnosti u novoroÄenÄadi i mladoj odrasloj populaciji. ToÄan uzrok ove bolesti nije poznat. Dok je u novoroÄenÄadi to najÄeÅ”Äe IgE posredovan odgovor na kravlje mlijeko i proteine soje, u odraslih je najÄeÅ”Äe rezultat CD4 Th2 odgovora. Endoskopskim pregledom zamijeÄene promjene stijenke kolona nespecifiÄne su, uslijed Äega je potrebna biopsija za potvrdu dijagnoze i iskljuÄenje drugih moguÄih bolesti. Upalne bolesti crijeva, lijekovi, paraziti, autoimune bolesti vezivnog tkiva, idiopatski hipereozinofilni sindrom mogu stvoriti sliÄnu kliniÄku i histoloÅ”ku sliku bolesti, zbog Äega je eozinofilni kolitis primarno dijagnoza iskljuÄenja. U djece je bolest nakon uvedene dijete samolimitirajuÄa dok je u odraslih potrebno dugotrajno lijeÄenje s obzirom na to da je bolest kroniÄna tijeka s razdobljima remisije i relapsa. NajuÄinkovitijom se pokazala kortikosteroidna terapija, a u sluÄaju teÅ”kih refraktornih stanja i razvoja steroidne ovisnosti uvodi se imunosupresivna terapija.Due to undefined diagnostic criteria and large number of secondary causes of eosinophilia, this disease is often late-detected. Patients are presented with unspecific symptoms such as abdominal pain, diarrhea, weight loss, and its clinical image mostly depends on the depth of eosinophilic infiltration of the intestinal wall. Eosinophilic colitis has bimodal age distribution with highest prevalence in newborns and young adult population. The exact cause of this disease remains unknown. While in infants the cause is most commonly IgE mediated response to cow's milk and soy protein, in adults it's most commonly the result of CD4 Th2 response. Endoscopically observed colon wall changes are unspecific, so biopsy is needed for conformation of the diagnosis and exclusion of other possible diseases. Inflammatory bowel diseases, medicines, parasites, autoimmune connective tissue diseases, idiopathic hypereosinophilic syndrome may create similar clinical presentation and histological findings, which is why eosinophilic colitis is primarily diagnosis of exclusion. In children, after dietary measures are introduced, the disease is self-limiting, whereas in adults long-term treatment is needed because it's a chronic relapsing disease with periods of remission. Corticosteroid therapy has proven to be the most effective, whereas in the cases of severe refractory conditions and development of steroid addiction immunosuppressive therapy is introduced
Effects of long-term multimodal psychosocial treatment on antipsychotic-induced metabolic changes in patients with first episode psychosis
Background: Antipsychotic-induced weight gain and metabolic abnormalities are one of the major challenges in the treatment of psychosis, contributing to the morbidity, mortality and treatment non-adherence. Different approaches were used to counteract these side effects but showed only limited or short-term effects. This study aims to analyse the effects of a long-term multimodal treatment program for first episode psychosis on antipsychotic-induced metabolic changes. ----- Methods: We enrolled 71 patients with first episode psychosis treated at the Zagreb University Hospital Centre from 2016 until 2018. Participants were assigned to one of the two groups: day hospital program vs. treatment as usual (TAU). Outcomes were: body weight, blood glucose, lipids and cholesterol, psychopathology and global level of functioning during the 18-months follow-up. ----- Results: Although the TAU group gained more weight and had higher increase of blood glucose, while the day hospital group had a higher increase in total cholesterol at 18th month follow-up, after the adjustment for age, gender and baseline measures, the type of treatment was not significantly associated with any of the primary outcome measures. Patients' psychopathology measures significantly decreased and their functional level significantly increased at month 18th in both groups. ----- Conclusion: While both types of treatment were effective in reducing psychopathology and restoring the patients' level of functioning, both were relatively ineffective in counteracting antipsychotic-induced metabolic abnormalities and antipsychotic-induced weight gain